• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach.用于预测轻度认知障碍老年人脑β淀粉样蛋白和tau蛋白状态的简单风险评分的开发:一种机器学习方法。
J Gerontol B Psychol Sci Soc Sci. 2025 Jun 10;80(7). doi: 10.1093/geronb/gbaf085.
2
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.载脂蛋白E4(APOE4)对可溶性和不溶性tau蛋白病理的影响主要受β-淀粉样蛋白的影响。
Brain. 2025 Jan 16. doi: 10.1093/brain/awaf016.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Impact of diabetes on the progression of Alzheimer's disease via trajectories of amyloid-tau-neurodegeneration (ATN) biomarkers.糖尿病通过淀粉样蛋白- tau-神经变性(ATN)生物标志物轨迹对阿尔茨海默病进展的影响。
J Nutr Health Aging. 2025 Feb;29(2):100444. doi: 10.1016/j.jnha.2024.100444. Epub 2024 Dec 10.
5
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
6
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
7
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
8
Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer's Disease.轻度认知障碍患者脑脊液中生长相关蛋白43(GAP-43)升高,通过淀粉样β蛋白(Aβ)积累增加与认知障碍相关,而在阿尔茨海默病中则转变为Aβ积累减少。
J Mol Neurosci. 2025 Mar 20;75(2):39. doi: 10.1007/s12031-025-02333-8.
9
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease.系统综述:液体生物标志物和机器学习方法改善从轻度认知障碍到阿尔茨海默病的诊断。
Alzheimers Res Ther. 2023 Oct 14;15(1):176. doi: 10.1186/s13195-023-01304-8.
10
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and Genotype in Alzheimer Disease.阿尔茨海默病中认知变化的时间进程和严重程度与β淀粉样蛋白(Aβ)阳性及基因型的关系
Neurology. 2025 Jul 22;105(2):e213853. doi: 10.1212/WNL.0000000000213853. Epub 2025 Jun 27.

本文引用的文献

1
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
2
Tau Beats Amyloid in Predicting Brain Atrophy in Alzheimer Disease: Implications for Prognosis and Clinical Trials.在预测阿尔茨海默病脑萎缩方面,tau蛋白比淀粉样蛋白更具优势:对预后和临床试验的启示
J Nucl Med. 2022 Jun;63(6):830-832. doi: 10.2967/jnumed.121.263694.
3
Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data.使用 A4 数据预测认知正常的老年人中的淀粉样蛋白阳性:一种机器学习方法。
Neurology. 2022 Jun 14;98(24):e2425-e2435. doi: 10.1212/WNL.0000000000200553. Epub 2022 Apr 25.
4
Predicting Abnormal Amyloid Burden: Can Machine Learning Become a Future Tool in Preventive Neurology?预测异常淀粉样蛋白负荷:机器学习能否成为预防神经病学未来的工具?
Neurology. 2022 Jun 14;98(24):999-1000. doi: 10.1212/WNL.0000000000200721. Epub 2022 Apr 25.
5
What's the cut-point?: a systematic investigation of tau PET thresholding methods.截断值是多少?tau PET 阈值方法的系统研究。
Alzheimers Res Ther. 2022 Apr 5;14(1):49. doi: 10.1186/s13195-022-00986-w.
6
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer's continuum.视空间记忆损伤作为预测阿尔茨海默病连续体中 tau 病理学的潜在神经认知标志物。
Alzheimers Res Ther. 2021 Oct 9;13(1):167. doi: 10.1186/s13195-021-00909-1.
7
Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline.阿尔茨海默病的液体和影像学标志物特征:tau PET 最能预测认知能力下降。
Mol Psychiatry. 2021 Oct;26(10):5888-5898. doi: 10.1038/s41380-021-01263-2. Epub 2021 Oct 1.
8
A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.《Aducanumab 进化概论:首款获批用于治疗阿尔茨海默病的抗体药物》。
J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.
9
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach.以多中心 PET 研究方法验证 centiloids 中淀粉样 PET 阳性阈值。
Alzheimers Res Ther. 2021 May 10;13(1):99. doi: 10.1186/s13195-021-00836-1.
10
Prediction of tau accumulation in prodromal Alzheimer's disease using an ensemble machine learning approach.使用集成机器学习方法预测前驱期阿尔茨海默病中的 tau 积累。
Sci Rep. 2021 Mar 11;11(1):5706. doi: 10.1038/s41598-021-85165-x.

用于预测轻度认知障碍老年人脑β淀粉样蛋白和tau蛋白状态的简单风险评分的开发:一种机器学习方法。

Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach.

作者信息

Petersen Kellen K, Nallapu Bhargav T, Lipton Richard B, Grober Ellen, Davatzikos Christos, Harvey Danielle J, Nasrallah Ilya M, Ezzati Ali

机构信息

Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.

Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

J Gerontol B Psychol Sci Soc Sci. 2025 Jun 10;80(7). doi: 10.1093/geronb/gbaf085.

DOI:10.1093/geronb/gbaf085
PMID:40326513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12202008/
Abstract

OBJECTIVES

The aim of this work is to use a machine learning framework to develop simple risk scores for predicting β-amyloid (Aβ) and tau positivity among individuals with mild cognitive impairment (MCI).

METHODS

Data for 657 individuals with MCI from the Alzheimer's Disease Neuroimaging Initiative (ADNI) data set were used. A modified version of AutoScore, a machine learning-based software tool, was used to develop risk scores based on hierarchical combinations of predictor categories, including demographics, neuropsychological assessments, APOE4 status, and imaging biomarkers.

RESULTS

The highest area under the receiver operating characteristic curve (AUC) for predicting Aβ positivity was 0.79, which was achieved by 2 separate models with predictors of age, Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog), APOE4 status, and either Trail Making Test Part B (TMT-B) or white matter hyperintensity. The best-performing model for tau positivity had an AUC of 0.91 using age, ADAS-13, and TMT-B scores, APOE4 information, abnormal hippocampal volume, and amyloid status as predictors.

DISCUSSION

Simple integer-based risk scores using available data could be used for predicting Aβ and tau positivity in individuals with MCI. Models have the potential to improve clinical trials through improved screening of individuals.

摘要

目的

本研究旨在使用机器学习框架开发简单的风险评分,以预测轻度认知障碍(MCI)个体的β-淀粉样蛋白(Aβ)和tau蛋白阳性情况。

方法

使用来自阿尔茨海默病神经影像学倡议(ADNI)数据集的657例MCI个体的数据。基于机器学习的软件工具AutoScore的修改版本,用于根据预测因子类别的分层组合开发风险评分,这些预测因子类别包括人口统计学、神经心理学评估、APOE4状态和影像学生物标志物。

结果

预测Aβ阳性的受试者工作特征曲线下面积(AUC)最高为0.79,这是由2个独立模型实现的,其预测因子为年龄、阿尔茨海默病评估量表认知子量表(ADAS-cog)、APOE4状态,以及连线测验B部分(TMT-B)或白质高信号。预测tau蛋白阳性的表现最佳的模型,使用年龄、ADAS-13、TMT-B评分、APOE4信息、海马体积异常和淀粉样蛋白状态作为预测因子,AUC为0.91。

讨论

使用现有数据的基于简单整数的风险评分可用于预测MCI个体的Aβ和tau蛋白阳性情况。这些模型有潜力通过改进个体筛查来改善临床试验。